nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ABCB1—adrenal gland cancer	0.813	1	CbGaD
Lovastatin—HDAC2—parathyroid gland—adrenal gland cancer	0.0144	0.182	CbGeAlD
Lovastatin—UGT1A1—urine—adrenal gland cancer	0.0117	0.147	CbGeAlD
Lovastatin—CYP2C19—urine—adrenal gland cancer	0.00635	0.0799	CbGeAlD
Lovastatin—PON3—pituitary gland—adrenal gland cancer	0.00592	0.0745	CbGeAlD
Lovastatin—ITGAL—adrenal gland—adrenal gland cancer	0.0054	0.0679	CbGeAlD
Lovastatin—CYP2C9—urine—adrenal gland cancer	0.00492	0.062	CbGeAlD
Lovastatin—CYP3A4—urine—adrenal gland cancer	0.00375	0.0472	CbGeAlD
Lovastatin—CYP2D6—urine—adrenal gland cancer	0.00369	0.0465	CbGeAlD
Lovastatin—Simvastatin—ABCB1—adrenal gland cancer	0.00361	0.505	CrCbGaD
Lovastatin—Pravastatin—ABCB1—adrenal gland cancer	0.00354	0.495	CrCbGaD
Lovastatin—HMGCR—adrenal cortex—adrenal gland cancer	0.0027	0.0339	CbGeAlD
Lovastatin—HDAC2—gonad—adrenal gland cancer	0.00247	0.0311	CbGeAlD
Lovastatin—HDAC2—pituitary gland—adrenal gland cancer	0.00241	0.0304	CbGeAlD
Lovastatin—HMGCR—gonad—adrenal gland cancer	0.00223	0.0281	CbGeAlD
Lovastatin—HMGCR—cardiac atrium—adrenal gland cancer	0.00223	0.0281	CbGeAlD
Lovastatin—HMGCR—pituitary gland—adrenal gland cancer	0.00218	0.0274	CbGeAlD
Lovastatin—HDAC2—adrenal gland—adrenal gland cancer	0.00216	0.0271	CbGeAlD
Lovastatin—HMGCR—adrenal gland—adrenal gland cancer	0.00195	0.0245	CbGeAlD
Lovastatin—ABCC2—adrenal gland—adrenal gland cancer	0.00141	0.0178	CbGeAlD
Lovastatin—CYP2C8—pituitary gland—adrenal gland cancer	0.00119	0.0149	CbGeAlD
Lovastatin—ABCB1—adrenal cortex—adrenal gland cancer	0.000704	0.00886	CbGeAlD
Lovastatin—ABCB1—gonad—adrenal gland cancer	0.000583	0.00734	CbGeAlD
Lovastatin—ABCB1—pituitary gland—adrenal gland cancer	0.000569	0.00716	CbGeAlD
Lovastatin—ABCB1—adrenal gland—adrenal gland cancer	0.000508	0.00639	CbGeAlD
Lovastatin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000295	0.00293	CbGpPWpGaD
Lovastatin—UGT1A3—Biological oxidations—POMC—adrenal gland cancer	0.000283	0.00282	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000278	0.00277	CbGpPWpGaD
Lovastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000276	0.00275	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	0.000275	0.00274	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—NR5A1—adrenal gland cancer	0.000255	0.00254	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SPARC—adrenal gland cancer	0.000254	0.00253	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—SDHB—adrenal gland cancer	0.000253	0.00252	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SH3KBP1—adrenal gland cancer	0.000252	0.00251	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000245	0.00243	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	0.000241	0.0024	CbGpPWpGaD
Lovastatin—UGT2B7—Biological oxidations—POMC—adrenal gland cancer	0.000241	0.0024	CbGpPWpGaD
Lovastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000239	0.00238	CbGpPWpGaD
Lovastatin—HDAC2—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	0.000239	0.00237	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ZNRF3—adrenal gland cancer	0.000237	0.00236	CbGpPWpGaD
Lovastatin—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000224	0.00223	CbGpPWpGaD
Lovastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000221	0.0022	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	0.000218	0.00217	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—BAD—adrenal gland cancer	0.000217	0.00216	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—SDHB—adrenal gland cancer	0.000215	0.00214	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—PRKACA—adrenal gland cancer	0.000215	0.00214	CbGpPWpGaD
Lovastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000214	0.00212	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000202	0.00201	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—BAD—adrenal gland cancer	0.000201	0.002	CbGpPWpGaD
Lovastatin—HDAC2—Cell Cycle—TP53—adrenal gland cancer	0.0002	0.00199	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—RRM1—adrenal gland cancer	0.0002	0.00199	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—SDHD—adrenal gland cancer	0.0002	0.00199	CbGpPWpGaD
Lovastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000197	0.00196	CbGpPWpGaD
Lovastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000197	0.00195	CbGpPWpGaD
Lovastatin—UGT1A1—Biological oxidations—POMC—adrenal gland cancer	0.000196	0.00195	CbGpPWpGaD
Lovastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000195	0.00194	CbGpPWpGaD
Lovastatin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000194	0.00193	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NOTCH—TP53—adrenal gland cancer	0.00019	0.00189	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GNRHR—adrenal gland cancer	0.00019	0.00189	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—SDHB—adrenal gland cancer	0.000188	0.00187	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—EGFR—adrenal gland cancer	0.000186	0.00185	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—EGFR—adrenal gland cancer	0.000185	0.00184	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	0.000183	0.00182	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—BRAF—adrenal gland cancer	0.000183	0.00182	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—CDC42—adrenal gland cancer	0.000182	0.00181	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—TP53—adrenal gland cancer	0.000181	0.0018	CbGpPWpGaD
Lovastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00018	0.00179	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000177	0.00176	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IGF2—adrenal gland cancer	0.000176	0.00175	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—SDHB—adrenal gland cancer	0.000175	0.00174	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—GNAS—adrenal gland cancer	0.000174	0.00173	CbGpPWpGaD
Lovastatin—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000173	0.00172	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000173	0.00172	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000172	0.00171	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000166	0.00165	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	0.000165	0.00164	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—RRM1—adrenal gland cancer	0.000163	0.00162	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—SDHD—adrenal gland cancer	0.000163	0.00162	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SDHB—adrenal gland cancer	0.00016	0.0016	CbGpPWpGaD
Lovastatin—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000159	0.00158	CbGpPWpGaD
Lovastatin—HDAC2—Factors involved in megakaryocyte development and platelet production—TP53—adrenal gland cancer	0.000159	0.00158	CbGpPWpGaD
Lovastatin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000158	0.00157	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—TP53—adrenal gland cancer	0.000156	0.00155	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MED12—adrenal gland cancer	0.000154	0.00153	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—MED12—adrenal gland cancer	0.000149	0.00148	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SPRY2—adrenal gland cancer	0.000149	0.00148	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000148	0.00147	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SDHB—adrenal gland cancer	0.000147	0.00146	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MEN1—adrenal gland cancer	0.000147	0.00146	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CTNNB1—adrenal gland cancer	0.000143	0.00142	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00014	0.0014	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—RRM1—adrenal gland cancer	0.000139	0.00138	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—SDHD—adrenal gland cancer	0.000139	0.00138	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MEN1—adrenal gland cancer	0.000136	0.00135	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000133	0.00133	CbGpPWpGaD
Lovastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000128	0.00128	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.000128	0.00127	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000126	0.00126	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—MED12—adrenal gland cancer	0.000122	0.00121	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—RRM1—adrenal gland cancer	0.000121	0.0012	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—SDHD—adrenal gland cancer	0.000121	0.0012	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00012	0.00119	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	0.000119	0.00118	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—TP53—adrenal gland cancer	0.000116	0.00116	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000114	0.00113	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000114	0.00113	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—EGFR—adrenal gland cancer	0.000113	0.00112	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—RRM1—adrenal gland cancer	0.000113	0.00112	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—SDHD—adrenal gland cancer	0.000113	0.00112	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000112	0.00111	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PRKACA—adrenal gland cancer	0.000109	0.00108	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000106	0.00106	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SDHB—adrenal gland cancer	0.000106	0.00106	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—EGFR—adrenal gland cancer	0.000105	0.00104	CbGpPWpGaD
Lovastatin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000104	0.00104	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000104	0.00104	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PRKACA—adrenal gland cancer	0.000104	0.00103	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000104	0.00103	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—MED12—adrenal gland cancer	0.000103	0.00103	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—SDHD—adrenal gland cancer	0.000103	0.00103	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—RRM1—adrenal gland cancer	0.000103	0.00103	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	0.000103	0.00103	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000102	0.00101	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TSHR—adrenal gland cancer	0.000101	0.00101	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	9.94e-05	0.000989	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	9.73e-05	0.000967	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	9.55e-05	0.000949	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MEN1—adrenal gland cancer	9.54e-05	0.000949	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—SDHD—adrenal gland cancer	9.49e-05	0.000943	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—RRM1—adrenal gland cancer	9.49e-05	0.000943	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SDHB—adrenal gland cancer	9.22e-05	0.000917	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	9.2e-05	0.000915	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—MED12—adrenal gland cancer	9.01e-05	0.000896	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	8.96e-05	0.000891	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PRKACA—adrenal gland cancer	8.88e-05	0.000883	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.88e-05	0.000883	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GNAS—adrenal gland cancer	8.83e-05	0.000878	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CDC42—adrenal gland cancer	8.82e-05	0.000877	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ABCB1—adrenal gland cancer	8.66e-05	0.000861	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	8.46e-05	0.000842	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—MED12—adrenal gland cancer	8.41e-05	0.000836	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	8.39e-05	0.000834	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SDHB—adrenal gland cancer	8.23e-05	0.000818	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.09e-05	0.000805	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	8.06e-05	0.000801	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SDHB—adrenal gland cancer	8.03e-05	0.000799	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—MED12—adrenal gland cancer	7.71e-05	0.000766	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SDHB—adrenal gland cancer	7.57e-05	0.000752	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PRKACA—adrenal gland cancer	7.55e-05	0.000751	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SDHB—adrenal gland cancer	7.5e-05	0.000746	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PRKACA—adrenal gland cancer	7.28e-05	0.000724	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.25e-05	0.000721	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GNAS—adrenal gland cancer	7.2e-05	0.000716	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TERT—adrenal gland cancer	7.08e-05	0.000704	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—MED12—adrenal gland cancer	7.07e-05	0.000703	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ABCB1—adrenal gland cancer	7.06e-05	0.000702	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	6.89e-05	0.000685	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—RRM1—adrenal gland cancer	6.86e-05	0.000682	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—SDHD—adrenal gland cancer	6.86e-05	0.000682	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	6.59e-05	0.000655	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PRKACA—adrenal gland cancer	6.57e-05	0.000654	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6.47e-05	0.000644	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	6.43e-05	0.000639	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDC42—adrenal gland cancer	6.18e-05	0.000614	CbGpPWpGaD
Lovastatin—HDAC2—Disease—BAD—adrenal gland cancer	6.15e-05	0.000612	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PRKACA—adrenal gland cancer	6.14e-05	0.00061	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GNAS—adrenal gland cancer	6.12e-05	0.000609	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.01e-05	0.000598	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ABCB1—adrenal gland cancer	6e-05	0.000597	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IGF2—adrenal gland cancer	5.95e-05	0.000592	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—POMC—adrenal gland cancer	5.94e-05	0.000591	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—RRM1—adrenal gland cancer	5.94e-05	0.000591	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—SDHD—adrenal gland cancer	5.94e-05	0.000591	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	5.9e-05	0.000587	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GNAS—adrenal gland cancer	5.9e-05	0.000587	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	5.89e-05	0.000586	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IGF1R—adrenal gland cancer	5.76e-05	0.000572	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PRKACA—adrenal gland cancer	5.62e-05	0.000559	CbGpPWpGaD
Lovastatin—HDAC2—Disease—BRAF—adrenal gland cancer	5.6e-05	0.000557	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—adrenal gland cancer	5.56e-05	0.000553	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	5.53e-05	0.00055	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	5.49e-05	0.000546	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GNAS—adrenal gland cancer	5.33e-05	0.00053	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—RRM1—adrenal gland cancer	5.3e-05	0.000527	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—SDHD—adrenal gland cancer	5.3e-05	0.000527	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ABCB1—adrenal gland cancer	5.23e-05	0.00052	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—SDHD—adrenal gland cancer	5.17e-05	0.000515	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—RRM1—adrenal gland cancer	5.17e-05	0.000515	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	5.16e-05	0.000513	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—MED12—adrenal gland cancer	5.11e-05	0.000508	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GNAS—adrenal gland cancer	4.97e-05	0.000494	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TERT—adrenal gland cancer	4.95e-05	0.000493	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SDHB—adrenal gland cancer	4.95e-05	0.000492	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ABCB1—adrenal gland cancer	4.88e-05	0.000485	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—RRM1—adrenal gland cancer	4.88e-05	0.000485	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—SDHD—adrenal gland cancer	4.88e-05	0.000485	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	4.87e-05	0.000484	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—POMC—adrenal gland cancer	4.85e-05	0.000482	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—SDHD—adrenal gland cancer	4.83e-05	0.000481	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—RRM1—adrenal gland cancer	4.83e-05	0.000481	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGS2—adrenal gland cancer	4.74e-05	0.000471	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.67e-05	0.000464	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GNAS—adrenal gland cancer	4.56e-05	0.000453	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTGS2—adrenal gland cancer	4.53e-05	0.00045	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ABCB1—adrenal gland cancer	4.47e-05	0.000445	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—MED12—adrenal gland cancer	4.43e-05	0.00044	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—BAD—adrenal gland cancer	4.31e-05	0.000429	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GNAS—adrenal gland cancer	4.18e-05	0.000416	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—POMC—adrenal gland cancer	4.12e-05	0.00041	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	4.1e-05	0.000408	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CTNNB1—adrenal gland cancer	4.05e-05	0.000403	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—POMC—adrenal gland cancer	3.97e-05	0.000395	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.96e-05	0.000394	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—MED12—adrenal gland cancer	3.95e-05	0.000393	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—BRAF—adrenal gland cancer	3.92e-05	0.00039	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.92e-05	0.00039	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—adrenal gland cancer	3.86e-05	0.000384	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—MED12—adrenal gland cancer	3.86e-05	0.000384	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	3.73e-05	0.000371	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—MED12—adrenal gland cancer	3.64e-05	0.000362	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—MED12—adrenal gland cancer	3.6e-05	0.000358	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—POMC—adrenal gland cancer	3.59e-05	0.000357	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.53e-05	0.000351	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—POMC—adrenal gland cancer	3.35e-05	0.000333	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—adrenal gland cancer	3.29e-05	0.000327	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	3.23e-05	0.000321	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.22e-05	0.00032	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—adrenal gland cancer	3.21e-05	0.000319	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.19e-05	0.000317	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.19e-05	0.000317	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.16e-05	0.000314	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—POMC—adrenal gland cancer	3.07e-05	0.000305	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GNAS—adrenal gland cancer	3.02e-05	0.000301	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	2.97e-05	0.000295	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	2.88e-05	0.000287	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—adrenal gland cancer	2.86e-05	0.000285	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CTNNB1—adrenal gland cancer	2.84e-05	0.000282	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.82e-05	0.00028	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—POMC—adrenal gland cancer	2.82e-05	0.00028	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.81e-05	0.00028	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—adrenal gland cancer	2.67e-05	0.000266	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.65e-05	0.000264	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	2.63e-05	0.000261	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GNAS—adrenal gland cancer	2.62e-05	0.00026	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.57e-05	0.000256	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	2.57e-05	0.000256	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—adrenal gland cancer	2.45e-05	0.000243	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.38e-05	0.000236	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GNAS—adrenal gland cancer	2.34e-05	0.000232	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	2.29e-05	0.000228	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.28e-05	0.000227	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—adrenal gland cancer	2.25e-05	0.000223	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	2.25e-05	0.000223	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.15e-05	0.000214	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GNAS—adrenal gland cancer	2.13e-05	0.000212	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.11e-05	0.00021	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	2.09e-05	0.000208	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—POMC—adrenal gland cancer	2.04e-05	0.000202	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—adrenal gland cancer	1.89e-05	0.000188	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—POMC—adrenal gland cancer	1.76e-05	0.000175	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.73e-05	0.000172	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	1.62e-05	0.000161	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.57e-05	0.000156	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—POMC—adrenal gland cancer	1.54e-05	0.000153	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.45e-05	0.000144	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—POMC—adrenal gland cancer	1.43e-05	0.000143	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	1.41e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.41e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.38e-05	0.000137	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.26e-05	0.000125	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.23e-05	0.000122	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.15e-05	0.000115	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	1.14e-05	0.000114	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—POMC—adrenal gland cancer	9.46e-06	9.41e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	7.55e-06	7.51e-05	CbGpPWpGaD
